- Home
- INTA vs BCRX Comparison
INTA vs BCRX Comparison
Compare INTA & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INTA | BCRX |
|---|---|---|
| Founded | 2000 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | INTA | BCRX |
|---|---|---|
| Price | $36.25 | $9.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $41.43 | $20.82 |
| AVG Volume (30 Days) | 800.4K | ★ 3.2M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 48.89 | ★ 381.40 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $504,120,000.00 | $25,186,000.00 |
| Revenue This Year | $15.91 | N/A |
| Revenue Next Year | $13.78 | $12.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.09 | N/A |
| 52 Week Low | $19.01 | $6.00 |
| 52 Week High | $47.93 | $11.22 |
Technical Indicators
Market Signals| Indicator | INTA | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical ComparisonAbout INTA Intapp Inc.
Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.